News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
17,571 Results
Type
Article (444)
Company Profile (1)
Press Release (17126)
Section
Business (9374)
Career Advice (5)
Deals (1571)
Drug Development (1431)
FDA (250)
Job Trends (460)
News (11740)
Policy (651)
Tag
2027 Pharm Country Standard (1)
Academia (58)
Allergies (3)
Alliances (538)
ALS (1)
Alzheimer's disease (23)
Antibody-drug conjugate (ADC) (8)
Approvals (271)
Artificial intelligence (4)
Autoimmune disease (4)
Best Places to Work (465)
Bladder cancer (7)
Brain cancer (1)
Breast cancer (25)
Cancer (136)
Cardiovascular disease (8)
Career advice (3)
CAR-T (11)
Cell therapy (20)
Clinical research (1343)
Collaboration (27)
Compensation (11)
COVID-19 (89)
CRISPR (6)
C-suite (4)
Cystic fibrosis (4)
Data (217)
Depression (3)
Diabetes (12)
Diagnostics (302)
Digital health (2)
Drug discovery (4)
Duchenne muscular dystrophy (10)
Earnings (9129)
Events (1583)
Executive appointments (3)
FDA (402)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (15)
Gene editing (6)
Gene therapy (2)
GLP-1 (22)
Government (116)
Guidances (94)
Healthcare (759)
HIV (2)
IgA nephropathy (6)
Immunology and inflammation (4)
Immuno-oncology (1)
Indications (1)
Infectious disease (97)
Inflammatory bowel disease (2)
Influenza (2)
Intellectual property (3)
Interviews (1)
IPO (1382)
Job creations (25)
Job search strategy (3)
Labor market (2)
Layoffs (8)
Legal (78)
Liver cancer (2)
Lung cancer (17)
Lymphoma (10)
Manufacturing (5)
MASH (5)
Medical device (635)
Medtech (639)
Mergers & acquisitions (200)
Metabolic disorders (27)
Multiple sclerosis (2)
NASH (4)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (50)
NextGen: Class of 2026 (111)
Non-profit (64)
Now hiring (2)
Obesity (9)
Ovarian cancer (2)
Pain (3)
Pancreatic cancer (7)
Parkinson's disease (8)
Patents (5)
Patient recruitment (5)
Peanut (2)
People (539)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (268)
Phase 2 (575)
Phase 3 (670)
Pipeline (410)
Postmarket research (41)
Preclinical (131)
Press Release (1)
Prostate cancer (6)
Radiopharmaceuticals (16)
Rare diseases (24)
Real estate (46)
Regulatory (548)
Reports (2)
Research institute (42)
Rett syndrome (5)
RSV (3)
Schizophrenia (12)
Series A (3)
Series B (1)
Sickle cell disease (4)
Special edition (1)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (26)
Supply chain (3)
Vaccines (20)
Venture capital (1)
Weight loss (5)
Women's health (1)
Date
Last 7 days (10)
Last 30 days (37)
Last 365 days (1070)
2026 (46)
2025 (1092)
2024 (1255)
2023 (1474)
2022 (1573)
2021 (1733)
2020 (4222)
2019 (1129)
2018 (775)
2017 (588)
2016 (296)
2015 (449)
2014 (289)
2013 (144)
2012 (194)
2011 (286)
2010 (294)
Location
Africa (9)
Arizona (11)
Asia (1010)
Australia (98)
California (433)
Canada (75)
China (28)
Colorado (15)
Connecticut (10)
Delaware (15)
Europe (2631)
Florida (49)
Georgia (8)
Illinois (27)
India (2)
Indiana (24)
Iowa (2)
Japan (11)
Kansas (6)
Kentucky (2)
Louisiana (4)
Maine (5)
Maryland (53)
Massachusetts (250)
Michigan (8)
Minnesota (18)
Missouri (5)
Montana (2)
Nevada (4)
New Hampshire (7)
New Jersey (149)
New York (87)
North Carolina (58)
Northern California (213)
Ohio (8)
Oregon (1)
Pennsylvania (94)
South America (21)
Southern California (176)
Tennessee (1)
Texas (45)
United States (1421)
Utah (25)
Virginia (4)
Washington State (20)
West Virginia (1)
Wisconsin (6)
17,571 Results for "211".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Privo Technologies Announces Milestone in PRV211 Arm of CLN-004 Clinical Trial: Primary Endpoint Met; No Serious Adverse Events Reported
January 26, 2026
·
3 min read
Press Releases
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
December 17, 2025
·
4 min read
Press Releases
Tuberculosis Therapeutics Market to Hit USD 2.11 Billion in 2025 on Rising Disease Burden
September 22, 2025
·
1 min read
Press Releases
Incyte Canada Announces Health Canada approval of Opzelura® (Ruxolitinib) Cream for the Treatment of Atopic Dermatitis in Children Ages 2-11
October 16, 2025
·
8 min read
Press Releases
Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
October 16, 2025
·
4 min read
Press Releases
KalVista Pharmaceuticals Presents New Data Highlighting Patient Satisfaction with EKTERLY® (sebetralstat) and its Potential in Children Ages 2-11 at the ACAAI 2025 Annual Scientific Meeting
November 7, 2025
·
9 min read
Press Releases
Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis
September 19, 2025
·
17 min read
Press Releases
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
June 19, 2025
·
5 min read
Press Releases
Update on FDA Review of Ruxolitinib Cream (Opzelura®) for Children Ages 2-11 with Atopic Dermatitis
June 23, 2025
·
13 min read
Press Releases
Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development
January 16, 2025
·
4 min read
1 of 1,758
Next
